| Members |
targetComponentId |
| Decreased testosterone level |
Decreased testosterone level |
| Decreased thyroid hormone level |
Decreased thyroid hormone level |
| Decreased thyroid stimulating hormone level |
Decreased thyroid stimulating hormone level |
| Decreased thyroxine level |
Decreased thyroxine level |
| Decreased triiodothyronine level |
Decreased triiodothyronine level (finding) |
| Decreased ureteral peristalsis |
Decreased ureteral peristalsis (finding) |
| Decreased vanillylmandelic acid level |
Decreased vanillylmandelic acid level (finding) |
| Decreased vibratory sense |
Decreased vibratory sense |
| Decreased vitamin A |
Decreased vitamin A |
| Decreased vitamin B |
Decreased vitamin B |
| Decreased vitamin B>12< |
Decreased vitamin B12 level (finding) |
| Decreased vitamin D |
Decreased vitamin D (finding) |
| Decreased vitamin K |
Decreased vitamin K |
| Decreased vitamin K>1< |
Decreased vitamin K>1< |
| Decreased vitamin K>2< |
Decreased vitamin K>2< |
| trycksår i koccyxregionen |
Pressure injury of coccygeal region of back (disorder) |
| Decubitus ulcer |
Pressure injury |
| Decubitus ulcer |
Pressure injury |
| trycksår |
Pressure injury |
| Decubitus ulcer |
Pressure injury |
| Decubitus ulcer (specify) |
Pressure injury |
| Decubitus ulcer |
Pressure injury |
| trycksår på ankel |
Pressure injury of ankle (disorder) |
| trycksår på bröst |
Pressure injury of breast (disorder) |
| trycksår på fotrygg |
Pressure injury of dorsum of foot |
| trycksår på höft |
Pressure injury of hip |
| trycksår på nedre delen av ryggen |
Pressure injury of lumbar region of back |
| trycksår i analfåran |
Pressure injury of natal cleft (disorder) |
| djup bröstmuskel, struktur |
Pectoral muscle structure |
| Deep pressure sore |
Pressure injury of deep tissue (disorder) |
| djupt trycksår |
Pressure injury of deep tissue (disorder) |
| Deficiency of N-acetylgalactosamine-6-sulfatase |
Deficiency of N-acetylgalactosamine-6-sulfatase |
| Deficiency of N-acetylglucosamine-6-sulfatase |
Mucopolysaccharidosis, MPS-III-D |
| brist på O-acetylserin (tiol)-lyas |
Specific enzyme deficiency |
| Deficiency of amniotic fluid production (disorder) |
Disorder of amniotic fluid production |
| Deficiency of amniotic fluid turnover (disorder) |
Disorder of amniotic fluid turnover |
| Deficiency of dihydrolipoamide dehydrogenase |
Dihydrolipoamide dehydrogenase deficiency |
| Deficiency of glutamate formyltransferase |
Glutamate formiminotransferase deficiency |
| Deficiency of glycerate dehydrogenase |
Primary hyperoxaluria, type II |
| Deficiency of glyoxylate reductase |
Primary hyperoxaluria, type II |
| Deficiency of iduronate-2-sulfatase |
Mucopolysaccharidosis, MPS-II |
| Deficiency of ornithine carbamoyltransferase |
Ornithine carbamoyltransferase deficiency |
| Deficiency of placental circulatory function |
Disorder of placental circulatory function |
| Deficiency of purine-nucleoside phosphorylase |
Purine-nucleoside phosphorylase deficiency |
| Deficiency of pyruvic dehydrogenase |
Pyruvate dehydrogenase complex deficiency |
| Defluvibacter lusatiensis |
Aquamicrobium lusatiense (organism) |
| Deformity due to adhesions |
Deformity |
| Degeneration of iris AND/OR ciliary body |
Disorder of uveal tract |
| Degenerative joint disease of thigh |
Disorder of lower extremity (disorder) |
| Dehydrogenase |
Dehydrogenase |
| Delay in sexual development and puberty, NEC |
Delay in sexual development AND/OR puberty |
| Delayed |
Delayed priority |
| Delayed exfoliation of primary teeth |
Persistent primary tooth (disorder) |
| fördröjd läkning av operationssår |
Delayed healing of surgical wound (finding) |
| Delayed healing surgical wound |
Delayed healing of surgical wound (finding) |
| Delayed healing surgical wound |
Delayed healing of surgical wound (finding) |
| 17q-deletionssyndromet |
Distal monosomy 17q (disorder) |
| Delta hepatitis viral agent |
Hepatitis D virus |
| delta-9-tetrahydrokannabinol 27 mg/ml + kannabinol 25 mg/ml, buckalsprej |
Product containing precisely cannabinol 25 milligram/1 milliliter and tetrahydrocannabinol 27 milligram/1 milliliter conventional release oral spray (clinical drug) |
| Demineralization of enamel of teeth |
Incipient enamel caries |
| dendritcellssarkom utan närmare specifikation |
Dendritic cell sarcoma |
| Dendroaspis viridis |
Dendroaspis angusticeps |
| Dendrocygnini |
Subfamily Dendrocygninae (organism) |
| dentalt medel för påvisande av plack |
Medicinal product categorised by therapeutic role |
| dentalt preparat för påvisande av plack |
Medicinal product categorised by therapeutic role |
| Denvershunt |
Peritoneovenous shunt |
| undersökning av Denvershunts öppenhet |
Peritoneovenous shunt patency test |
| Deoxycortisol |
Cortodoxone |
| Deoxycortisone |
Cortodoxone |
| administrering av Provera depot-injektion |
Injection of medroxyprogesterone acetate (procedure) |
| administrering av depåpreventivmedel |
Administration of depot contraceptive (procedure) |
| Depth of cells in anterior chamber |
Depth of anterior chamber |
| Derangement of meniscus, NEC |
Derangement of meniscus |
| Dermatitis atrophicans |
Acrodermatitis atrophicans chronica |
| Dermatitis due to other specified substance taken internally |
Dermatitis due to substances taken internally (disorder) |
| dermatofibrom |
Dermatofibroma (morphologic abnormality) |
| dermatos av misstänkt viral etiologi |
Suspected viral infection of skin (situation) |
| Dermographism |
Dermatographic urticaria |
| flytande desfluran 99 % |
Product containing precisely desflurane 990 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
| desloratadin 0,5 mg/ml, sirap |
Product containing precisely desloratadine 500 microgram/1 milliliter conventional release oral solution (clinical drug) |
| desloratadin 2,5 mg/pseudoefedrin 120 mg, tablett med modifierad frisättning |
Product containing only desloratadine and pseudoephedrine in oral dose form (medicinal product form) |
| desloratadin 2,5 mg + pseudoefedrin 120 mg, depåtablett |
Product containing only desloratadine and pseudoephedrine in oral dose form (medicinal product form) |
| desloratadin 5 mg/pseudoefedrin 240 mg, tablett med modifierad frisättning |
Product containing only desloratadine and pseudoephedrine in oral dose form (medicinal product form) |
| desloratadin 5 mg + pseudoefedrin 240 mg, depåtablett |
Product containing only desloratadine and pseudoephedrine in oral dose form (medicinal product form) |
| desmoplastiskt fibrom |
Desmoplastic fibroma |
| desmopressinacetat 0,01 %, lösning |
Product containing only desmopressin (medicinal product) |
| deoximetason 0,5 %, gel |
Product containing only desoximetasone (medicinal product) |
| Destruction of intervertebral disc by other specified method |
Vertebral column destructive procedure |
| Destruction of tissue of heart |
Catheter ablation of tissue of heart |
| Destruction of tissue of pharynx |
Pharynx destructive procedure |
| Destructive procedure of facial bone |
Facial bone destructive procedure |
| Desulfotomaculum orientis |
Desulfosporosinus orientis |
| detrusorhyperreflexi i urinblåsan |
Neurogenic detrusor overactivity |
| Detrusor instability |
Idiopathic detrusor overactivity (disorder) |
| Detrusor instability |
Idiopathic detrusor overactivity (disorder) |
| Detrusor instability |
Idiopathic detrusor overactivity (disorder) |
| blåsa med detrusorinstabilitet |
Idiopathic detrusor overactivity (disorder) |
| dexametason 0,5 mg/5 ml, elixir |
Dexamethasone 100 microgram/mL oral solution |
| Dexamethasone sodium phospha 0.05% |
Dexamethasone only product in ocular dose form |
| Dexamethasone sodium phospha 0.1% solution |
Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release eye solution (clinical drug) |
| Dexamethasone sodium phospha 1mg/cc solution |
Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release eye solution (clinical drug) |
FHIR